Retinal Disease

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Lilly to acquire Adverum Biotechnologies

Lucid Diligence Brief: Lilly to acquire Adverum Biotechnologies Professional…

by Timos Papagatsias

EURETINA 2025 Preview: Key Retinal Disease Highlights to Watch

EURETINA 2025 at a glance Looking ahead to EURETINA 2025, LucidQuest outlines…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - July 17th 2025

🧬 This Week in Gene & Cell Therapy: Diabetes Deals, Vision Breakthroughs,…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - July 10th 2025

🧬 This Week in Gene & Cell Therapy: Hearing Restored, CAR-T Expands, and…

by LucidQuest

Rare Disease news

Rare Diseases Weekly News - April 24th 2025

This Week in Rare Disease Breakthroughs 🧬 | Gene Therapies, Drug Approvals…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.